The Australian Cardiovascular Alliance (ACvA) has formally issued a letter of support for the PHASES project, following an impactful presentation by Professor Kim Greaves at the Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand (CSANZ) in August 2025.

The PHASES project — which focuses on improving cardiovascular outcomes through integrated digital health solutions and evidence-based implementation strategies — was highlighted at the conference as a model for how research translation can drive real-world change in heart health care across Australia.

Professor Greaves’ presentation showcased how PHASES leverages data-driven insights, clinical collaboration and community engagement to enhance prevention, diagnosis and management of cardiovascular disease.

The project’s approach resonated strongly with ACvA’s mission to accelerate innovation and strengthen national cardiovascular research capacity.

In announcing ACvA’s support, Chief Executive Officer Rob Tassie said the PHASES project exemplifies the kind of cross-sector collaboration needed to transform cardiovascular health outcomes.

The ACvA’s endorsement underscores the growing emphasis on collaborative, technology-enabled approaches to tackling Australia’s leading cause of death. By supporting PHASES, the Alliance reinforces its commitment to fostering innovation that bridges the gap between research and clinical care.

The PHASES team will continue to work with ACvA and other partners to expand the project’s reach and evaluate its impact across diverse healthcare settings in the coming year.

View the ACvA letter of support.